UPMC Enterprises announces $1 billion commitment to life sciences investments
The Translational Sciences team at UPMC Enterprises will be investing $1 billion by 2024 to develop new drugs, diagnostics, and devices.
Comprehensive Genetic Sequencing in Clinical Care: How to Get it Right
At UPMC, we are committed to building a health system where the right patient gets the right care, in the right way, at the right time, every time. The “Rights” of clinical management…
A Look to the Future
As 2019 comes to a close, we have seen many different trends and topics discussed on our blog. From new technologies and investments to breakthroughs in the digital health industry, we wanted to know what our team was most excited to see in 2020.
UPMC joins investment round for Werewolf Therapeutics
UPMC Enterprises has invested in a biotech startup company pursuing new approaches to boosting the …